These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
347 related items for PubMed ID: 18596599
1. Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer. Vogel VG. Menopause; 2008; 15(4 Suppl):782-9. PubMed ID: 18596599 [Abstract] [Full Text] [Related]
4. [Review of risk factors for breast cancer--what's new?]. Haimov-Kochman R, Lavy Y, Hochner-Celinkier D. Harefuah; 2002 Aug; 141(8):702-8, 761. PubMed ID: 12222134 [Abstract] [Full Text] [Related]
5. Genetic and environmental predictors, endogenous hormones and growth factors, and risk of estrogen receptor-positive breast cancer in Japanese women. Yoshimoto N, Nishiyama T, Toyama T, Takahashi S, Shiraki N, Sugiura H, Endo Y, Iwasa M, Fujii Y, Yamashita H. Cancer Sci; 2011 Nov; 102(11):2065-72. PubMed ID: 21790896 [Abstract] [Full Text] [Related]
6. Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women. Johansson H, Gandini S, Bonanni B, Mariette F, Guerrieri-Gonzaga A, Serrano D, Cassano E, Ramazzotto F, Baglietto L, Sandri MT, Decensi A. Breast Cancer Res Treat; 2008 Mar; 108(1):57-67. PubMed ID: 17468953 [Abstract] [Full Text] [Related]
8. Screening and follow-up of the patient at high risk for breast cancer. Willey SC, Cocilovo C. Obstet Gynecol; 2007 Dec; 110(6):1404-16. PubMed ID: 18055740 [Abstract] [Full Text] [Related]
10. Does a family history of cancer increase the risk for postmenopausal endometrial carcinoma? A prospective cohort study and a nested case-control family study of older women. Olson JE, Sellers TA, Anderson KE, Folsom AR. Cancer; 1999 Jun 01; 85(11):2444-9. PubMed ID: 10357416 [Abstract] [Full Text] [Related]
14. Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk. Col NF, Chlebowski RT. Menopause; 2008 Jun 01; 15(4 Suppl):804-9. PubMed ID: 18596602 [Abstract] [Full Text] [Related]
15. Breast cancer risk factors in younger and older women. Chun J, Pocock B, Joseph KA, El-Tamer M, Klein L, Schnabel F. Ann Surg Oncol; 2009 Jan 01; 16(1):96-9. PubMed ID: 18979140 [Abstract] [Full Text] [Related]
17. Age-specific trends in mammographic density: the Minnesota Breast Cancer Family Study. Kelemen LE, Pankratz VS, Sellers TA, Brandt KR, Wang A, Janney C, Fredericksen ZS, Cerhan JR, Vachon CM. Am J Epidemiol; 2008 May 01; 167(9):1027-36. PubMed ID: 18385204 [Abstract] [Full Text] [Related]
18. Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer. Higgins SA, Matloff ET, Rimm DL, Dziura J, Haffty BG, King BL. Breast Cancer Res; 2005 May 01; 7(6):R1017-22. PubMed ID: 16280052 [Abstract] [Full Text] [Related]
19. Impact of hormone replacement therapy on the histologic subtype of breast cancer. Zanetti-Dällenbach RA, Krause EM, Lapaire O, Gueth U, Holzgreve W, Wight E. Arch Gynecol Obstet; 2008 Nov 01; 278(5):443-9. PubMed ID: 18335229 [Abstract] [Full Text] [Related]
20. [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer]. Aulmann S, Penzel R, Schirmacher P, Sinn HP. Verh Dtsch Ges Pathol; 2007 Nov 01; 91():208-13. PubMed ID: 18314616 [Abstract] [Full Text] [Related] Page: [Next] [New Search]